Julie A I Thoms

14PUBLICATIONS
79CO-AUTHORS
Medical infection agents (incl. prions)Medical mycologyMolecular targetsGene and molecular therapyHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 14, 2026
PU.1 inflames lower-risk MDS.

|Oct 08, 2025
MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemia.

Dorien Pastoors, Marije Havermans, Roger Mulet-Lazaro

|May 13, 2025
Clinical response to azacitidine in MDS is associated with distinct DNA methylation changes in HSPCs.

Julie A I Thoms, Feng Yan, Henry R Hampton

|Aug 28, 2024
TOPORS E3 ligase mediates resistance to hypomethylating agent cytotoxicity in acute myeloid leukemia cells.

Peter Truong, Sylvie Shen, Swapna Joshi

|Oct 23, 2023
BloodChIP Xtra: an expanded database of comparative genome-wide transcription factor binding and gene-expression profiles in healthy human stem/progenitor subsets and leukemic cells.

Julie A I Thoms, Forrest C Koch, Alireza Raei

|Sep 22, 2023
The NCOR-HDAC3 co-repressive complex modulates the leukemogenic potential of the transcription factor ERG.

Eitan Kugler, Shreyas Madiwale, Darren Yong

Pageof 3

Frequent Collaborators

11 joint publications

John Pimanda

4 joint publications

Ashwin Unnikrishnan

3 joint publications

Fatemeh Vafaee

3 joint publications

Stefan K Bohlander